Search
Descriptor English: Axitinib
Descriptor Spanish: Axitinib
Descriptor axitinib
Entry term(s) AG 013736
AG-013736
AG013736
Inlyta
Scope note: Derivado de benzamida e indazol que actúa como inhibidor de la TIROSINCINASA de los RECEPTORES DE FACTORES DE CRECIMIENTO ENDOTELIAL VASCULAR. Se usa en el tratamiento del CARCINOMA DE CÉLULAS RENALES avanzado.
Descriptor Portuguese: Axitinibe
Descriptor French: Axitinib
Entry term(s): AG-013736
AG013736
Tree number(s): D02.065.277.051
D02.241.223.100.100.115
D02.455.426.559.389.127.085.093
D03.383.129.539.487.065
D03.633.100.449.065
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000077784
Scope note: A benzamide and indazole derivative that acts as a TYROSINE KINASE inhibitor of the VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR. It is used in the treatment of advanced RENAL CELL CARCINOMA.
Allowable Qualifiers: AA analogues et dérivés
AD administration et posologie
AE effets indésirables
AG agonistes
AI antagonistes et inhibiteurs
AN analyse
BL sang
CF liquide cérébrospinal
CH composition chimique
CL classification
CS synthèse chimique
EC économie
HI histoire
IM immunologie
IP isolement et purification
ME métabolisme
PD pharmacologie
PK pharmacocinétique
PO intoxication
RE effets des radiations
SD ressources et distribution
ST normes
TO toxicité
TU usage thérapeutique
UR urine
Pharm Action: Antineoplastic Agents
Protein Kinase Inhibitors
Registry Number: C9LVQ0YUXG
CAS Type 1 Name: Benzamide, N-methyl-2-((3-((E)-2-(2-pyridinyl)ethenyl)-1H-indazol-6-yl)thio)-
DeCS ID: 57757
Unique ID: D000077784
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/05/21
Axitinib - Preferred
Concept UI M0489638
Preferred term Axitinib
AG-013736 - Narrower
Concept UI M0496201
Preferred term AG-013736
Entry term(s) AG013736



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey